RA
PFE icon

Ransom Advisory’s Pfizer PFE Stock Holding History

Ransom Advisory’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$492K Sell
19,749
-1,399
-7% -$35.3K 0.19% 86
2025
Q3 		$539K Buy
21,148
+8
+0% +$197 0.24% 68
2025
Q2 		$512K Buy
21,140
+7
+0% +$163 0.24% 71
2025
Q1 		$536K Sell
21,133
-144
-0.7% -$3.77K 0.26% 72
2024
Q4 		$564K Buy
21,277
+4,807
+29% +$130K 0.26% 72
2024
Q3 		$477K Sell
16,470
-597
-3% -$17.4K 0.22% 84
2024
Q2 		$478K Sell
17,067
-140
-0.8% -$3.85K 0.24% 81
2024
Q1 		$478K Buy
+17,207
New +$477K 0.25% 84

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ransom Advisory's PFE Position: Q4 2025 in Review

Ransom Advisory reduced its Pfizer (PFE) stake by 6.6% in Q4 2025, selling an estimated $35.3K and leaving 19,749 shares worth $492K. The position accounts for 0.19% of the portfolio, ranked #86.

Ransom Advisory first reported a position in PFE in Q1 2024 and has held it in 8 quarters since. The position peaked at $564K in Q4 2024. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Ransom Advisory held 19,749 shares of Pfizer worth $492K as of Q4 2025.
  • Ransom Advisory sold 1,399 Pfizer shares in Q4 2025, an estimated $35.3K.
  • Pfizer made up 0.19% of Ransom Advisory's portfolio in Q4 2025, its #86 holding.
  • Ransom Advisory first reported a position in Pfizer in Q1 2024 and has held it in 8 quarters since.
  • Ransom Advisory's Pfizer position peaked at $564K in Q4 2024.
  • 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.